Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sang Jun Yoon

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
Journal of Microbiology (Seoul, Korea)|March 5, 2025
Synbiotic combination of fructooligosaccharides and probiotics ameliorates the metabolic dysfunction-associated steatotic liver diseaseSang Yoon Lee, Su-Been Lee, Goo-Hyun Kwon, et al.
Cells|September 23, 2022
Elucidation of Prebiotics, Probiotics, Postbiotics, and Target from Gut Microbiota to Alleviate Obesity via Network Pharmacology StudyKi-Kwang Oh, Haripriya Gupta, Byeong-Hyun Min, et al.
Scientific Reports|January 13, 2023
The identification of metabolites from gut microbiota in NAFLD via network pharmacologyKi-Kwang Oh, Haripriya Gupta, Byeong Hyun Min, et al.
Artificial Cells, Nanomedicine, and Biotechnology|May 2, 2023
The seamless integration of dietary plant-derived natural flavonoids and gut microbiota may ameliorate non-alcoholic fatty liver disease: a network pharmacology analysisKi-Kwang Oh, Haripriya Gupta, Raja Ganesan, et al.
International Journal of Molecular Sciences|August 26, 2022
The Link between Gut Microbiota and Hepatic EncephalopathySung-Min Won, Ki Kwang Oh, Haripriya Gupta, et al.
Microorganisms|February 25, 2022
The <i>Lactobacillus</i> as a Probiotic: Focusing on Liver DiseasesJin-Ju Jeong, Hee Jin Park, Min Gi Cha, et al.
Probiotics and Antimicrobial Proteins|March 12, 2024
Multistrain Probiotics Alleviate Diarrhea by Modulating Microbiome-Derived Metabolites and Serotonin PathwayJin-Ju Jeong, Yoo-Jeong Jin, Raja Ganesan, et al.
Artificial Cells, Nanomedicine, and Biotechnology|April 30, 2024
A consortium of <i>Hordeum vulgare</i> and gut microbiota against non-alcoholic fatty liver disease via data-driven analysisSu-Been Lee, Haripriya Gupta, Byeong-Hyun Min, et al.
Biomedicines|March 25, 2022
Gut Microbiome in Non-Alcoholic Fatty Liver Disease: From Mechanisms to Therapeutic RoleHaripriya Gupta, Byeong-Hyun Min, Raja Ganesan, et al.
Artificial Cells, Nanomedicine, and Biotechnology|December 23, 2022
New insight into gut microbiota-derived metabolites to enhance liver regeneration via network pharmacology studyKi-Kwang Oh, Ickwon Choi, Haripriya Gupta, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Journal of Microbiology (Seoul, Korea)|March 5, 2025
Synbiotic combination of fructooligosaccharides and probiotics ameliorates the metabolic dysfunction-associated steatotic liver diseaseSang Yoon Lee, Su-Been Lee, Goo-Hyun Kwon, et al.
Cells|September 23, 2022
Elucidation of Prebiotics, Probiotics, Postbiotics, and Target from Gut Microbiota to Alleviate Obesity via Network Pharmacology StudyKi-Kwang Oh, Haripriya Gupta, Byeong-Hyun Min, et al.
Scientific Reports|January 13, 2023
The identification of metabolites from gut microbiota in NAFLD via network pharmacologyKi-Kwang Oh, Haripriya Gupta, Byeong Hyun Min, et al.
Artificial Cells, Nanomedicine, and Biotechnology|May 2, 2023
The seamless integration of dietary plant-derived natural flavonoids and gut microbiota may ameliorate non-alcoholic fatty liver disease: a network pharmacology analysisKi-Kwang Oh, Haripriya Gupta, Raja Ganesan, et al.
International Journal of Molecular Sciences|August 26, 2022
The Link between Gut Microbiota and Hepatic EncephalopathySung-Min Won, Ki Kwang Oh, Haripriya Gupta, et al.
Microorganisms|February 25, 2022
The <i>Lactobacillus</i> as a Probiotic: Focusing on Liver DiseasesJin-Ju Jeong, Hee Jin Park, Min Gi Cha, et al.
Probiotics and Antimicrobial Proteins|March 12, 2024
Multistrain Probiotics Alleviate Diarrhea by Modulating Microbiome-Derived Metabolites and Serotonin PathwayJin-Ju Jeong, Yoo-Jeong Jin, Raja Ganesan, et al.
Artificial Cells, Nanomedicine, and Biotechnology|April 30, 2024
A consortium of <i>Hordeum vulgare</i> and gut microbiota against non-alcoholic fatty liver disease via data-driven analysisSu-Been Lee, Haripriya Gupta, Byeong-Hyun Min, et al.
Biomedicines|March 25, 2022
Gut Microbiome in Non-Alcoholic Fatty Liver Disease: From Mechanisms to Therapeutic RoleHaripriya Gupta, Byeong-Hyun Min, Raja Ganesan, et al.
Artificial Cells, Nanomedicine, and Biotechnology|December 23, 2022
New insight into gut microbiota-derived metabolites to enhance liver regeneration via network pharmacology studyKi-Kwang Oh, Ickwon Choi, Haripriya Gupta, et al.
Pageof 9